Table 1.
Clinical Characteristics of Enrolled Patients
| N = 46 | |
|---|---|
| Age, median (range) | 26 (18–57) |
| Male, n (%) | 21 (45.6%) |
| Days from diagnosis to quarantine (March 4 or 11, 2020),a median (range) | 6.5 (4.0–18.0) |
| Days from diagnosis to fecal sample examination (April 4 or 5, 2020),b median (range) | 37.0 (29.0–41.0) |
| Days from diagnosis to last follow-up evaluation (April 24, 2020), median (range) | 52.0 (39.0–61.0) |
| Medical history, digestive, n (%) | 11 (23.9%) |
| Reflux esophagitis | 6 (13.0%) |
| Gastritis | 3 (6.5%) |
| Gastric ulcer | 0 |
| Irritable bowel disease | 3 (6.5%) |
| Inflammatory bowel disease | 0 |
| Fatty liver | 1 (2.1%) |
| Viral hepatitis | 0 |
| Cirrhosis | 0 |
| Pancreatitis | 0 |
| Cholecystitis | 0 |
| Cholangitis | 0 |
| Medical history, others,c n (%) | 3 (6.5%) |
| General symptoms from diagnosis to last follow-up evaluation, n (%) | 38 (82.6%) |
| Feverd | 1 (2.2%) |
| Headache | 12 (26.1%) |
| Myalgia | 6 (13.0%) |
| Cough | 17 (36.9%) |
| Sputum | 26 (56.5%) |
| Rhinorrhea | 15 (32.6%) |
| Nasal obstruction | 5 (10.9%) |
| Chest pain | 7 (15.2%) |
| Anosmia | 4 (8.7%) |
| Fatigue | 11 (23.9%) |
| Loss of appetite | 1 (2.2%) |
a
Group 1 on March 4, 2020, and group 2 on March 11, 2020.
b
Group 1 on April 4, 2020, and group 2 on April 5, 2020.
c
Other diseases included gout (n = 1), thyroid cancer (n = 1), and pneumothorax (n = 1).
d
Fever occurred after quarantine in 1 patient.